99mTc-rhAnnexin V-128 a Phase I/IIa Study in Patients With Rheumatoid Arthritis (RA) or Ankylosing Spondylitis (AS)

NCT02328027 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Low recruitment

Conditions

Rheumatoid Arthritis
Ankylosing Spondylitis

Interventions

DRUG: 99mTc-rhAnnexin V-128

Sponsor

Advanced Accelerator Applications